Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer
Open Access
- 5 June 2024
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 24 (1) , 1-15
Abstract
Ferroptosis, an iron-dependent regulated cell death mechanism, holds significant promise as a therapeutic strategy in oncology. In the current study, we explored the regulatory effects of epigallocatechin gallate (EGCG), a prominent polyphenol in green tea, on ferroptosis and its potential therapeutic implications for non-small cell lung cancer (NSCLC). Treatment of NSCLC cell lines with varying concentrations of EGCG resulted in a notable suppression of cell proliferation, as evidenced by a reduction in Ki67 immunofluorescence staining. Western blot analyses demonstrated that EGCG treatment led to a decrease in the expression of glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11) while increasing the levels of acyl-CoA synthetase long-chain family member 4 (ACSL4). These molecular changes were accompanied by an increase in intracellular iron, malondialdehyde (MDA), and reactive oxygen species (ROS), alongside ultrastructural alterations characteristic of ferroptosis. Through small RNA sequencing and RT-qPCR, transfer RNA-derived small RNA 13502 (tsRNA-13502) was identified as a significant target of EGCG action, with its expression being upregulated in NSCLC tissues compared to adjacent non-tumorous tissues. EGCG was found to modulate the ferroptosis pathway by downregulating tsRNA-13502 and altering the expression of key ferroptosis regulators (GPX4/SLC7A11 and ACSL4), thereby promoting the accumulation of iron, MDA, and ROS, and ultimately inducing ferroptosis in NSCLC cells. This study elucidates EGCG’s multifaceted mechanisms of action, underscoring the modulation of ferroptosis as a viable therapeutic approach for enhancing NSCLC treatment outcomes.Keywords
Funding Information
- the Special Clinical Research Project of the Shanghai Municipal Health Commission (202140473)
- Health System Peak Discipline Construction Project of Xuhui District, Shanghai (SHXHZDXK202312)
This publication has 41 references indexed in Scilit:
- ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–Cell Death & Differentiation, 2019
- Targeting Ferroptosis to Iron Out CancerCancer Cell, 2019
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapySeminars in Cancer Biology, 2018
- Epigallocatechin‐3‐gallate inhibited cancer stem cell–like properties by targeting hsa‐mir‐485‐5p/RXRα in lung cancerJournal of Cellular Biochemistry, 2018
- The biology and management of non-small cell lung cancerNature, 2018
- Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling PathwayInternational Journal of Biological Sciences, 2017
- Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancerProceedings of the National Academy of Sciences, 2016
- Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green teaBritish Journal of Pharmacology, 2012
- PAST, PRESENT AND FUTURE OF AEDES-ALBOPICTUS IN THE UNITED-STATES1990
- Neutrophil elastase α1-proteinase inhibitor complexes in pleural effusionsJournal of Molecular Medicine, 1988